Earlier this year, IVP general partner Tom Loverro proclaimed that the post-pandemic downturn is over, and companies that made it this far should prioritize growth over cost-cutting.
Yet, the companies still struggling to raise their next round of financing at a higher valuation or survive altogether could still be in the thousands, according to Brian Hirsch, co-founder of Tribeca Venture Partners.
The 13-year-old firm has a late-stage strategy that, unlike conventional growth funds, invests in companies forced to raise capital at a valuation that’s the same or lower than their last price. In many of these situations, existing investors are ready to support the company with additional funding, but they need a third party like Tribeca Ventures to value the deal, Hirsch told TechCrunch.
VCs are excited to back AI companies at red-hot valuations, “but everything else is really challenged,” Hirsch said.
Nothing proves more just how much of a tale of two cities venture has become than the latest valuation data from Carta. The cap-table management platform analyzed nearly 2,000 software deals that closed this year and found that the bottom 10% of Series B deals had a pre-money valuation of only $40 million, meanwhile, the top 10% of companies at the same stage of development were priced at almost $1 billion.
The price dispersion was even more stark for Series D deals, ranging from a mere $27 million to $5.2 billion.
The companies at the upper end of the range are undoubtedly doing something having to do with AI. Notable examples include ElevenLabs, which raised a $80 million Series B earlier this year, valuing the company at $920 million pre-money, and Cohere, which closed its Series D at a $5 billion pre-money valuation.
Disrupt 2026: The tech ecosystem, all in one room
Your next round. Your next hire. Your next breakout opportunity. Find it at TechCrunch Disrupt 2026, where 10,000+ founders, investors, and tech leaders gather for three days of 250+ tactical sessions, powerful introductions, and market-defining innovation. Register now to save up to $400.
Save up to $300 or 30% to TechCrunch Founder Summit
1,000+ founders and investors come together at TechCrunch Founder Summit 2026 for a full day focused on growth, execution, and real-world scaling. Learn from founders and investors who have shaped the industry. Connect with peers navigating similar growth stages. Walk away with tactics you can apply immediately
Offer ends March 13.
For non-AI startups, the fundraising landscape is drastically different, even if they raised capital after the ZIRP-era frenzy subsided.
Non-AI companies that raised a Series A round 18 months ago are likely facing challenges in securing Series B funding, even with decent revenue growth, Hirsch said.
Founders of non-GenAI startups must feel like “in high school, and they didn’t get invited to the cool party,” Hirsch said, adding that they often have a good business, but nobody cares.
Indeed, Carta’s data reveals that only 9% of Series A companies have been able to secure Series B funding within two years, a significant decline from the previous 25%.
However, Tribeca Ventures is using its growth fund to help price down rounds of more mature startups, primarily companies that have revenues of $20 million or above.
Many of these startups are growing at a decent pace, but their valuations are too high for the current market.
“We’re still in that unwinding process,” Hirsch said. “We think it’s at least a couple years more of clean-up work.”
